Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

G. Gorzegno · SciRah

Researcher profile · Semantic Scholar

G. Gorzegno

Share profile

G. Gorzegno — researcher profile on SciRah

h-index: 24
Works: 75
Citations: 2,576

Most-cited papers

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial.
Miguel Martín, F. Holmes, B. Ejlertsen, S. Delaloge +496 more
2017The Lancet Oncology512 citations
Semantic Scholar
Incidence of skeletal complications in patients with bone metastatic prostate cancer and hormone refractory disease: predictive role of bone resorption and formation markers evaluated at baseline.
A. Berruti, L. Dogliotti, R. Bitossi, Giuseppe Fasolis +6 more
2000Journal of Urology213 citations
Semantic Scholar
Nine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER study‡
P. Conte, A. Frassoldati, G. Bisagni, A. Brandes +80 more
2018Annals of Oncology153 citations Open access
Semantic Scholar
p53 but not bcl-2 immunostaining is predictive of poor clinical complete response to primary chemotherapy in breast cancer patients.
A. Bottini, A. Berruti, A. Bersiga, M. Brizzi +11 more
2000Clinical Cancer Research132 citations
Semantic Scholar
Multivariate regression analyses of data from a randomised, double-blind, placebo-controlled study confirm quality of life benefit of epoetin alfa in patients receiving non-platinum chemotherapy
L. Fallowfield, D. Gagnon, M. Zagari, Davide Cella +5 more
2002British Journal of Cancer117 citations Open access
Semantic Scholar
Differential patterns of bone turnover in relation to bone pain and disease extent in bone in cancer patients with skeletal metastases.
A. Berruti, L. Dogliotti, G. Gorzegno, M. Torta +7 more
1999Clinical Chemistry115 citations Open access
Semantic Scholar
Multimodal management of stages III-IVa malignant thymoma.
S. Bretti, A. Berruti, C. Loddo, P. Sperone +10 more
2004Lung Cancer113 citations
Semantic Scholar
Prognostic value in predicting overall survival of two mucinous markers: CA 15-3 and CA 125 in breast cancer patients at first relapse of disease.
A. Berruti, Marco Tampellini, M. Torta, T. Buniva +2 more
1994European Journal of Cancer101 citations
Semantic Scholar
Relationship between CA 15-3 serum levels and disease extent in predicting overall survival of breast cancer patients with newly diagnosed metastatic disease.
M. Tampellini, A. Berruti, A. Gerbino, T. Buniva +9 more
1997British Journal of Cancer86 citations Open access
Semantic Scholar
Primary chemotherapy with adriamycin, cisplatin, vincristine and cyclophosphamide in locally advanced thymomas: a single institution experience
A. Berruti, P. Borasio, A. Gerbino, G. Gorzegno +6 more
1999British Journal of Cancer82 citations Open access
Semantic Scholar
Time to progression in metastatic breast cancer patients treated with epirubicin is not improved by the addition of either cisplatin or lonidamine: final results of a phase III study with a factorial design.
A. Berruti, R. Bitossi, G. Gorzegno, A. Bottini +16 more
2002Journal of Clinical Oncology79 citations
Semantic Scholar
Predictive factors for skeletal complications in hormone-refractory prostate cancer patients with metastatic bone disease
A. Berruti, Marcello Tucci, A. Mosca, R. Tarabuzzi +9 more
2005British Journal of Cancer70 citations Open access
Semantic Scholar
Circulating chromogranin A in the assessment of patients with neuroendocrine tumours. A single institution experience.
M. Stivanello, A. Berruti, M. Torta, A. Termine +4 more
2001Annals of Oncology70 citations Open access
Semantic Scholar
Biochemical evaluation of bone turnover in cancer patients with bone metastases: relationship with radiograph appearances and disease extension.
A. Berruti, Alessandro Piovesan, M. Torta, C. Raucci +4 more
1996British Journal of Cancer67 citations Open access
Semantic Scholar
Potential clinical value of circulating chromogranin A in patients with prostate carcinoma.
A. Berruti, L. Dogliotti, A. Mosca, G. Gorzegno +7 more
2001Annals of Oncology51 citations Open access
Semantic Scholar
Neoadjuvant chemotherapy with adriamycin, cisplatin, vincristine and cyclophosphamide (ADOC) in invasive thymomas: results in six patients.
A. Berruti, P. Borasio, A. Roncari, G. Gorzegno +2 more
1993Annals of Oncology51 citations Open access
Semantic Scholar
Phase II study of vinorelbine with protracted fluorouracil infusion as a second- or third-line approach for advanced breast cancer patients previously treated with anthracyclines.
A. Berruti, P. Sperone, A. Bottini, G. Gorzegno +9 more
2000Journal of Clinical Oncology50 citations
Semantic Scholar
Prognostic significance of disordered calcium metabolism in hormone-refractory prostate cancer patients with metastatic bone disease
Marcello Tucci, A. Mosca, G. Lamanna, F. Porpiglia +13 more
2009Prostate Cancer and Prostatic Diseases43 citations Open access
Semantic Scholar
Prognostic significance of changes in CA 15-3 serum levels during chemotherapy in metastatic breast cancer patients
M. Tampellini, A. Berruti, R. Bitossi, G. Gorzegno +16 more
2006Breast Cancer Research and Treatment43 citations
Semantic Scholar
Restless legs syndrome and its relationship with anxiety, depression, and quality of life in cancer patients undergoing chemotherapy
L. Ostacoli, Andrea Saini, L. Ferini-Strambi, V. Castronovo +9 more
2010Quality of Life Research39 citations
Semantic Scholar
The clinical management of neuroendocrine tumors with long-acting repeatable (LAR) octreotide: comparison with standard subcutaneous octreotide therapy.
L. Dogliotti, M. Tampellini, M. Stivanello, G. Gorzegno +1 more
2001Annals of Oncology36 citations Open access
Semantic Scholar
Effects of the somatostatin analog lanreotide on the circulating levels of chromogranin‐A, prostate‐specific antigen, and insulin‐like growth factor‐1 in advanced prostate cancer patients
A. Berruti, L. Dogliotti, A. Mosca, R. Tarabuzzi +5 more
2001The Prostate31 citations
Semantic Scholar
The role of haemoglobin level in predicting the response to first-line chemotherapy in advanced colorectal cancer patients
M. Tampellini, Andrea Saini, Irene Alabiso, R. Bitossi +12 more
2006British Journal of Cancer30 citations Open access
Semantic Scholar
Independent Factors Predict Supranormal CA 15-3 Serum Levels in Advanced Breast Cancer Patients at First Disease Relapse
M. Tampellini, A. Berruti, G. Gorzegno, R. Bitossi +15 more
2001Tumor Biology25 citations
Semantic Scholar
Background to and Management of Treatment-Related Bone Loss in Prostate Cancer
A. Berruti, M. Tucci, C. Terrone, G. Gorzegno +3 more
2002Drugs & Aging18 citations
Semantic Scholar
ICON2: randomised trial of single-agent carboplatin against three-drug combination of CAP (cyclophosphamide, doxorubicin, and cisplatin) in women with ovarian cancer. ICON Collaborators. International Collaborative Ovarian Neoplasm Study
Mkb Parmar, Torri, A. Bonaventura, C. Bonazzi +215 more
199818 citations
Semantic Scholar
Multicenter Phase II trial of intermediate dose cisplatin and vinorelbine in inoperable non-small cell lung cancer patients.
S. Bretti, A. Berruti, G. Gorzegno, P. La Ciura +6 more
1996Lung Cancer18 citations
Semantic Scholar
Gemcitabine and protracted 5-fluorouracil infusion as third-line chemotherapy in refractory colorectal cancer patients.
R. Bitossi, C. M. Sculli, M. Tampellini, I. Alabiso +7 more
2008Anticancer Research17 citations
Semantic Scholar
Recall inflammatory skin reaction after use of pegylated liposomal doxorubicin in site of previous drug extravasation.
Andrea Saini, A. Berruti, P. Sperone, R. Bitossi +3 more
2006The Lancet Oncology16 citations
Semantic Scholar
Comparison of Assay of Total and Bone-Specific Alkaline Phosphatase in the Assessment of Osteoblast Activity in Patients with Metastatic Bone Disease
Alessandro Piovesan, A. Berruti, M. Torta, R. Cannone +6 more
1997Calcified Tissue International16 citations
Semantic Scholar
Oral estramustine plus oral etoposide in the treatment of hormone refractory prostate cancer patients: a phase II study with a 5-year follow-up.
A. Berruti, E. Fara, M. Tucci, R. Tarabuzzi +10 more
2005Urologic oncology14 citations
Semantic Scholar
Systemic recurrence of endometrial cancer more than 10 years after hysterectomy: a report of two cases and a brief review of the literature
L. Muratori, P. Sperone, G. Gorzegno, A. La Salvia +1 more
2020Journal of the Egyptian National Cancer Institute13 citations Open access
Semantic Scholar
Evaluation by dual energy X-ray absorptiometry of changed bone density in metastatic bone sites as a consequence of systemic treatment.
A. Berruti, L. Dogliotti, G. Osella, Stefania Cerutti +5 more
2000Oncology Report13 citations
Semantic Scholar
p 53 but not bcl-2 Immunostaining Is Predictive of Poor Clinical Complete Response to Primary Chemotherapy in Breast Cancer Patients 1
A. Bottini, A. Berruti, A. Bersiga, M. Brizzi +11 more
200012 citations
Semantic Scholar
Long-term disease free survival in a patient with metastatic adreno-cortical carcinoma after complete pathological response to chemotherapy plus mitotane
P. Sperone, A. Berruti, G. Gorzegno, P. Paccotti +4 more
2006Journal of Endocrinological Investigation11 citations
Semantic Scholar
Paclitaxel, vinorelbine and 5-fluorouracil in breast cancer patients pretreated with adjuvant anthracyclines
A. Berruti, R. Bitossi, G. Gorzegno, A. Bottini +13 more
2005British Journal of Cancer10 citations Open access
Semantic Scholar
Vinorelbine as second line treatment in anthracycline pre-treated advanced breast cancer patients: A phase II study
L. Dogliotti, G. Gorzegno, M. Baù, A. Farris +2 more
199310 citations
Semantic Scholar
Hypertriglyceridemia during Long-Term Interferon-Alpha Therapy: Efficacy of Diet and Gemfibrosil Treatment. A Case Report
A. Berruti, G. Gorzegno, Graziella Vitetta, M. Tampellini +1 more
1992Tumori10 citations
Semantic Scholar
Paclitaxel administration on days 1 and 8 every 21 days in anthracycline-pretreated metastatic breast cancer patients. A multicenter phase II trial
M. Donadio, E. Manzin, A. Berruti, A. Bottini +10 more
2001Cancer Chemotherapy and Pharmacology9 citations
Semantic Scholar
Acute Myeloblastic Leukemia Associated with Mediastinal Nonseminomatous Germ Cell Tumors. Report on two Cases
A. Berruti, E. Pazè, E. Fara, G. Gorzegno +1 more
1995Tumori8 citations
Semantic Scholar
Variation in gynecological oncology follow-up practice: attributable to cancer centers or to patient characteristics? A Piedmont Regional Oncology Network Study.
L. Fuso, A. Evangelista, E. Pagano, E. Piovano +26 more
2011Tumori7 citations
Semantic Scholar
Durable complete remission after weekly docetaxel administration in a patient with mediastinal non-seminomatous germ-cell tumor refractory to cisplatin-based chemotherapy.
A. Berruti, Andrea Saini, G. Gorzegno, Marco Tampellini +2 more
2003Annals of Oncology5 citations Open access
Semantic Scholar
Long-term disease control in a metastatic squamous cell carcinoma of the oral cavity treated with maintenance metronomic capecitabine
L. Muratori, A. La Salvia, G. Gorzegno, P. Sperone +1 more
2020Journal of Oncology Pharmacy Practice4 citations
Semantic Scholar
Variation in gynecological oncology follow-up practice: Attributable to cancer centers or to patient characteristics? A Piedmont Regional Oncology Network Study
L. Fuso, A. Evangelista, E. Pagano, E. Piovano +27 more
20114 citations
Semantic Scholar
Mediastinal non-seminomatous germ cell tumours: effectiveness of platinum, etoposide, bleomycin combination chemotherapy plus adjunctive surgery.
A. Berruti, Piero Borasio, E. Pazè, Claudio Mossetti +2 more
1992European Journal of Cancer4 citations
Semantic Scholar
Long term control of luteinized thecoma with sclerosing peritonitis with leuprorelin and tamoxifen treatment
L. Muratori, G. Gorzegno, Paola Sperone, A. Andreozzi +2 more
2019Gynecologic Oncology Reports3 citations Open access
Semantic Scholar
Is an Antiemetic Prophylactic Treatment Needed for Patients Submitted to Consecutive Days of 5-fluorouracil? An Observational Study
V. de Angelis, F. Roila, M. Tonato, E. Ballatori +80 more
2001Tumori3 citations Open access
Semantic Scholar
Objective response to epirubicin and lonidamine. A case of advanced thymoma previously treated with the ADOC scheme and unresponsive to paclitaxel plus cyclophosphamide.
A. Berruti, M. Tampellini, G. Gorzegno, L. Dogliotti
1997Chest3 citations
Semantic Scholar
Heparin neutralizes serum antiplasmin inhibition of peripheral blood leukocyte fibrinolytic activity.
F. Ghezzo, S. Romano, Raffaela Mazzone, G. Gorzegno +1 more
1987Thrombosis Research3 citations
Semantic Scholar
Risk of depressive events in long-term surviving patients affected by hormone-related cancer according to time after diagnosis.
Andrea Saini, L. Ostacoli, G. Gorzegno, R. Picci +3 more
2009Journal of Clinical Oncology2 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

L. Dogliotti×27
Invite
L. Dogliotti — researcher profile on SciRah
A. Berruti×21
Invite
A. Berruti — researcher profile on SciRah
A. Berruti×16
Invite
A. Berruti — researcher profile on SciRah
L. Dogliotti×14
Invite
L. Dogliotti — researcher profile on SciRah

×11

Invite

M. Tampellini — researcher profile on SciRah

Invite

M. Torta — researcher profile on SciRah

Invite

R. Bitossi — researcher profile on SciRah

Invite

S. Danese — researcher profile on SciRah

Alberto Angeli×7

Invite

Alberto Angeli — researcher profile on SciRah

Invite

M. Donadio — researcher profile on SciRah

Invite

A. Bottini — researcher profile on SciRah

F. Porpiglia×5

Invite

F. Porpiglia — researcher profile on SciRah